Assistant Professor
The Ohio State University College of Pharmacy
Columbus, Ohio
Mengying Hu, PhD, is an Assistant Professor of the Division of Pharmaceutics and Pharmacology, College of Pharmacy at The Ohio State University (OSU). She is an NCATS K12 Scholar (2025-2027) and member of the OSU Comprehensive Cancer Center. She received PhD in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill, followed by a postdoc training on extracellular vesicle (EV) biology and immuno-oncology in Weill Cornell Medical College.
Dr. Hu’s multidisciplinary research group (https://www.hoo-lab.com) is dedicated to elucidating the functions and mechanisms of immune cell-derived EVs, with a particular emphasis on the role of EV-associated DNA in immune modulation. In parallel, her lab explores both synthetic and naturally occurring nanoparticles for therapeutic applications. A major focus includes the design and optimization of lipid nanoparticles (LNPs) for the targeted delivery of nucleic acids—such as mRNA, siRNA, and plasmid DNA—to specific disease sites. Ultimately, her research aims to guide the rational design of next-generation non-viral gene therapies and EV-based diagnostic and prognostic tools.
Disclosure information not submitted.
Priming Immune-Evasive Tumors with T cell-derived Extracellular Vesicles
Wednesday, November 12, 2025
10:45 AM - 11:00 AM CT